COMBINATION OF A CYANOPYRROLIDINE WITH A HEPATIC GLUCONEOGENESIS INHIBITOR
摘要
<p>A medicament comprising a cyanopyrrolidine derivative having a supeirior DPP-IV inhibitory activity in combination with a hepatic gluconeogenesis inhibitor, which medicament provides a prophylactic or therapeutic agent for diabetes having an effective hypoglycemic action with few side effects in many diabetic patients.</p>
